Phil East

Fascinating talk by Boro Dropulic from Caring Cross on plans to improve affordability and access to CAR T-cell therapy. I liked production at the point of care, a companion facility on site to engineer the T-cells. Good work on mitigating antigen loss and improving persistence.

NHS to begin world-first trial of AI tool to identify type 2 diabetes risk Exclusive: Two London hospital trusts to trial tool that can predict those at risk up to 13 years before condition develops

Early intervention and prevention of type II diabetes using AI www.theguardian.com/society/2024...

Hi Erik,

Can you please add me to the science feed. I am head of Clinical BioInformatics @ Gustave Roussy orcid.org/0000-0001-5801-5713
Thank you 🙏

Phil

How to build the virtual cell with artificial intelligence: Priorities and opportunities Advances in AI and omics enable the creation of AI virtual cells (AIVCs)—multi-scale, multimodal neural network models that simulate molecules, cells, and tissues across diverse states. This vision outlines their design and collaborative development, promising to transform biological research through high-fidelity simulations, accelerating discoveries, and fostering interdisciplinary open science collaborations.

Interesting to see virtual cells back in the news. The full realisation of this epic ambition is of course someway off, however it's going to be a driver for AI applied to omics data. Good to see #openscience highlighted #AIVC #stanford #CZI #genetech

www.cell.com/cell/fulltex...

Very happy to be here on #bluesky after making a break from other increasingly politically skewed platforms.

This is a great idea, can you me as well, thank you.